SAVIMS

Vaccine risk benefit analysis

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Should COVID-19 Vaccination in Children be Mandatory?

Reference: Benn, C. S., & Aaby, P. (2021). Should COVID-19 be a vaccine disease or a childhood disease? The BMJ, 374, n1687. https://doi.org/10.1136/bmj.n1687 Summary: The article discusses the implications of COVID-19 vaccination for children, highlighting concerns over the safety and necessity of such measures. It critiques the small sample size of the Pfizer phase 3 […]

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID Vaccine Safety Concerns: An Analysis

Reference: Kirsch, S. (2021). All you need to know about COVID vaccine safety. COVID-19 Early Treatment Fund. Summary: Steve Kirsch, Executive Director of the COVID-19 Early Treatment Fund, argues that COVID vaccines may be responsible for more deaths than they prevent. He estimates over 150,000 excess deaths associated with the vaccines, contrasting this figure with

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Understanding Efficacy and Effectiveness of Vaccines

Reference: Joi, P. (2020). What is the difference between efficacy and effectiveness? Gavi, the Vaccine Alliance. Retrieved from https://www.gavi.org/vaccineswork/what-difference-between-efficacy-and-effectiveness Summary: Efficacy and effectiveness are two crucial terms in vaccine science, often conflated but distinct. Efficacy refers to the performance of a vaccine under ideal, controlled conditions, typically demonstrated in clinical trials where a vaccinated group

General Health, Immunology, Other viral illnesses, Peer-reviewed evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Immunosuppression After Measles Vaccination

Reference: Smedman, L., Joki, A., da Silva, A. P., Troye-Blomberg, M., Aronsson, B., & Perlmann, P. (1994). Immunosuppression after measles vaccination. Acta Paediatrica, 83(2), 164-168. https://doi.org/10.1111/j.1651-2227.1994.tb13043.x Summary: The study investigates the effects of live attenuated measles vaccination on cellular immune responses in children from Sweden and Guinea-Bissau. Sixteen children from each region were assessed before

Scroll to Top